M. leprae in some patients makes further investigations necessary in these 2 directions. Pettit, Rees and Ridley (1966) claim to have demonstrated the phenomenon of drug resistance in 9 patients in one of the largest in-patient leprosaria in the world, in Malaysia.
In the Acworth Leprosy Hospital when promin was the first sulphone tried it was noted that some patients did not improve. Such patients wcre found to be excreting the drug rapidly. An increase of the dose resulted in satisfactory improvement. Thus was engendered the concept in the Acworth Leprosy Hospital that the rate of excretion of sulphones had some correlation with improvement.
In recent years 2 patients were encountered in which a satisfactory response could be obtained after raising the dose of DDS to 150 and 200 mgm. dailyt (i.e., 0.9 and 1.2 gm.
per week). Improvement noticed with high dose treatment in a few patients prompted us to study the rate of excretion and blood concentration of DDS in different subj ects after a test dose.
MATERIAL AND METHODS
Two hundred patients (182 males and 18 females) of ages ranging from 12 to 65 years attending the Acworth Leprosy Hospital, Wadala, were the subjects for the study . Only patients without evident kidney disease were selected. The types of leprosy from which these patients were suffering were as follows:- Before investigation routine anti-leprosy treat ment was stopped in all patients for varying periods till the urine did not show even a trace of DDS . The minimum number of days after which no DDS was found was 10 days and the maximum 30 days.
Mter an oral test dose of 100 mgm . of DDS the quantity of total diazotizable material excreted during the subsequent 24 hours was estimated in all the patients by the method described by Simpson (1949) (calorimetric estimation of the coupled compound of diazotized sulphone with N I-naphthyl ethylene diamine dihydrochloride). The estimations were made on a Klett-Summerson Photoelectric calorimeter.
Blood concentration of the c1mg at 2, 4, 6, 8 and 24 hours after the administration of the drug was studied in 47 patients .
The urinary excretion pattern of 16 patients was studied by repeating the test at intervals of one month, 3 months, and 12 or 14 months.
The wcight of the patients was not taken into consideration, though we feel that the dose in relation to the weight should be an important fa ctor to be considered in future investigations. The average of the range of difference is 9.07 mgm . which is within the limits of experi mental error.
RESULTS
Here it must be mentioned that wherever possible the collection of urine was done at the hospital. In a few cases the samples of urine were brought by the patients. The completeness of the collection of urine excreted in 24 hours will in future be checked by a determination of its creatinine content .
COMMENTS
From Table 2 it is evident that the 24-hour excretory pattern of DDS following an oral test dose varies within wide limits in different patients . Fairly consistent blood concentration curves of DDS could be obtained (Graph 1) co-relating to the excretory pattern.
In the case of patients excreting more than 70 mgm. in 24 hours (Graph 2) the peak con centration in the blood is reached 6 hours after administration of the drug, while in those excreting less than 30 mgm. it occurs at 8 hours. Though the maximum blood concentration is more in the case of the former there is a tendency for the concentration to drop down earlier during 24 hours than in the latter case. The implications of such a 24-hour study in patients receiving prolonged DDS treatment remains to be investigated. However it may be stated that the possibility of more sustained blood levels of �HOU RS-7
GRAPH 2
Showing blood concentration curves of patients excreting less than 30 mgm. and more than 70 mgm . of DDS.
DDS in patients who excrete DDS at a slow rate may account for prolonged tissue con centrations of the drug at high levels in such patients.
The figures in Table 3 point to an apparent consistency of the urinary excretion pattern in the same individual when re-tested at intervals of one month, 3 months, and 12 or 14 months.
The next question that arises is what correlation exists between the excretory pattern and reactions and improvement in leprosy patients under treatment with DDS. Table 4 shows reactions in all types of patients (lepromatous, borderline, reactional, tuberculoid, tuberculoid major) in relation to their excretion rates.
The majority of patients with reaction are within the 30-55 mgm. excretion group . However, it has to be appreciated that the causes of reactions in leprosy are numerous and some of these reactions may have been due to causes other than DDS treatment.
An attempt was made to study the excretory pattern in patients under treatment when in reaction. It was found that although the usual treatment dose of DDS was stopped excretion of DDS continued in appreciable amounts for as long as the reaction persisted. This aspect is receiving close attention.
With regard to improvement in relation to the excretory pattern the improvement noted in the registers against non-lepromatous patients is subject to human error as there is no yard stick to assess the improvement acurately. In lepromatous patients the number of bacilli is the criterion.
However, it must also be mentioned that a number of patients are given tablets of DDS reguarly but they do not take them regularly. Such patients will not show improvement, but they will be taken for assessment as receiving regular treatment. To give an example, the following may be quoted:-G.S.R., male, aged 16 years in 1957, noted as taking treatment for 65 months out of 108 months. The DDS estimation done in 1966 showed that he was taking tablets (he may have taken tablets a few days previously) yet there was no improvement. He was admitted as an in patient and the taking of tablets was supervised. He showed bacteriological improvement.
To avoid all fallacies therefore, lepromatous patients rendered negative without reactions, should be taken for assessment and not patients who show only improvement. In the series of lepromatous patients studied only one such patient exists. This patient was rendered negative by treatment over a period of 10 years. This presentation fo cuses attention to the wide variations in the urinary excretory pattern of DDS in leprosy patients, the probable im mutability of the pattern in individuals, and the apparent correlation of the excretory pattern with improvement and leactions.
In 200 patients studied excretions as low as 18.01 mgm . and as high as 86.07 me,m. were encountered during 24 hours following an oral test dose of 100 mgm. DDS.
The excretory pattern of individuals seemed to be constant on re-testing at intervals of 1, 3 and 12 months.
The majority of reactions were noted in the 30 to 55 mgm. range of excretors. As the causes of reactions are multifarious the findings in reaction patients are not taken as a basis for standardizing slow, moderate or rapid excretors.
Due to paucity of bacteriologically negative lepromatous patients without reactions cor relation between excretory rate and improve ment could not be determined.
